Related Experiment Video
Updated: Jun 28, 2025
Author Spotlight: Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System
Published on: May 12, 2023
Review on Emerging Therapeutic Strategies for Managing Cardiovascular Disease
Minal Narkhede1, Avinash Pardeshi1, Rahul Bhagat1
1SMBT College of Pharmacy, Nandi Hills Dhamangaon Taluka Igatpuri, Nashik 422403, India.
Insights
Innovative cardiovascular disease (CVD) treatments are emerging, including new drugs, gene therapy, AI, and digital health tools. These advancements, alongside lifestyle changes, aim to transform CVD management and reduce global health burdens.
Area of Science:
- Cardiology
- Pharmacology
- Biotechnology
- Digital Health
Background:
- Cardiovascular disease (CVD) presents a significant global health challenge with substantial economic implications.
- Traditional therapies for CVD have limitations, necessitating the development of progressive and innovative interventions.
- Understanding the evolving epidemiological landscape of CVD is crucial for effective disease management.
Purpose of the Study:
- To provide a comprehensive overview of the latest advancements in cardiovascular therapeutics.
- To explore emerging pharmacological, biotechnological, and digital health strategies for CVD management.
- To synthesize current knowledge and guide clinicians and researchers in navigating the dynamic field of cardiovascular disease treatment.
Main Methods:
- Review of novel pharmacological interventions, including drug development, targeted therapies, and drug repurposing.
- Exploration of gene therapy, artificial intelligence (AI), and machine learning (ML) in cardiovascular medicine.
- Investigation of non-pharmacological approaches such as digital health technologies, wearable devices, telemedicine, regenerative medicine, and stem cell therapies.
- Analysis of the role of lifestyle modifications, diet, exercise, and behavioral changes in CVD prevention and management.
Main Results:
- Emerging pharmacological strategies offer new avenues for targeted CVD treatment.
- Gene therapy holds potential for addressing genetic predispositions to cardiovascular disorders.
- AI and ML are increasingly integrated for improved risk assessment and treatment optimization.
- Digital health, regenerative medicine, and lifestyle interventions represent transformative tools in CVD care.
- Precision medicine approaches are gaining prominence in tailoring cardiovascular treatments.
Conclusions:
- A synthesis of emerging therapeutic modalities is essential for advancing cardiovascular disease management.
- The integration of novel pharmacological, biotechnological, and digital health strategies promises to transform CVD care.
- Lifestyle modifications remain a cornerstone of cardiovascular health and disease prevention.
- Continued research and collaboration are vital to alleviate the global burden of CVD and promote cardiovascular health.
Abstract:
Cardiovascular disease (CVD) remains a foremost global health concern, necessitating ongoing exploration of innovative therapeutic strategies. This review surveys the latest developments in cardiovascular therapeutics, offering a comprehensive overview of emerging approaches poised to transform disease management. The examination begins by elucidating the current epidemiological landscape of CVD and the economic challenges it poses to healthcare systems. It proceeds to scrutinize the limitations of traditional therapies, emphasizing the need for progressive interventions. The core focus is on novel pharmacological interventions, including advancements in drug development, targeted therapies, and repurposing existing medications. The burgeoning field of gene therapy and its potential in addressing genetic predispositions to cardiovascular disorders are explored, alongside the integration of artificial intelligence and machine learning in risk assessment and treatment optimization. Non-pharmacological interventions take center stage, with an exploration of digital health technologies, wearable devices, and telemedicine as transformative tools in CVD management. Regenerative medicine and stem cell therapies, offering promises of tissue repair and functional recovery, are investigated for their potential impact on cardiac health. This review also delves into the interplay of lifestyle modifications, diet, exercise, and behavioral changes, emphasizing their pivotal role in cardiovascular health and disease prevention. As precision medicine gains prominence, this synthesis of emerging therapeutic modalities aims to guide clinicians and researchers in navigating the dynamic landscape of cardiovascular disease management, fostering a collective effort to alleviate the global burden of CVD and promote a healthier future.
Related Concept Videos
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
01:18Cardiovascular Drugs: Classification based on Therapeutic Indications
01:25Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
01:31Adrenergic Antagonists: ɑ and β-Receptor Blockers
01:16Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
01:17Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...